INTRODUCTION
Multiple system atrophy (MSA)l in man is frequently associated with degeneration of sympathetic nervous system (Shy-Drager syndrome) (1, 2) , which is reflected by low endogenous concentrations of norepinephrine (3, 4) . This degeneration results in denervation supersensitivity in the form of increased pharmacological responses to exogenous adrenergic agonists (4, 5) . The supersensitivity results, in part, from defective baroreflexes (4), but impaired catecholamine clearance is probably important (4) . It is unknown whether the increased responses to adrenergic agonists are also due to changes in the number or alterations in the nature of adrenergic receptors. This paper demonstrates an increase in the number of specific binding sites, presumably alpha receptors, for [3H]dihydroergocryptine [3H]DHE, a radiolabeled binding ligand, with alpha receptors on platelets isolated from patients with MSA who had denervation supersensitivity shown by increased pressor responses to the alpha agonist norepinephrine.
METHODS
Subjects. Five normal male volunteers (age 23-65) were compared with eight subjects (age 39-72) (three female) with MSA and sympathetic nervous degeneration. In the MSA subjects, testing of autonomic function showed postural hypotension, loss of systolic overshoot in the Valsalva manoeuvre, and lack of a pressor response to stress indicating a sympathetic efferent lesion with baroreceptor reflex loss (4) . All MSA subjects had low recumbent plasma norepinephrine concentrations (measured radioenzymatically [6] , (0.42±0.09 nM; normal [3] 3.47±0.58 nM, P < 0.0005, unpaired t test), which did not increase after 600 tilt for 10 min. The diagnosis of MSA with autonomic failure was made by the criteria outlined in references (3) and (4) . None of the normal or MSA subjects were receiving any drugs for at least 2 wk before the study.
Norepinephrine infusions. The pressor responses of the MSA subjects to intravenous norepinephrine were compared with those in seven of the normal subjects (age 28-65). The studies had the informed consent of all the MSA and normal subjects, all were free of recognizable cardiac disease and had normal electrocardiographs. The electrocardiograph and blood pressure (measured by sphygmonometer) were multiple system atrophy; Rt, platelets' alpha receptors concentration.
monitored continuously throughout the norepinephrine infusions and emergency facilities were at hand. All subjects were supine for 1 h before and during infusion studies carried out at 1400 h. (±)Norepinephrine bitartrate (Levophed, Winthrop Laboratories, Sterling-Winthrop House, Surbitonon-Thames, Surrey, England), (in saline, 0.85%) was infused stepwise (each dose for 5 min) at 50, 100, and 150 ng/kg-' per min-in normal and 1.5, 3, and 6 ng/kg-' per min-' in MSA subjects via a brachial venous cannula (Abbocath 16 G, Abbott Diagnostics, Diagnostic Products, Abbott Labs Ltd., Queenborough Kent, ME 11 SEL, England) using a Meltech constant infusion pump. In each case, the responses were compared with infusion of 0.85% saline placebo, which caused no changes in blood pressure or heart rate. In normal subjects, blood pressure and heart rate were not changed by norepinephrine at 1.5-6 ng/kg-1 per min-'. Alpha receptor binding studies. Receptor binding studies were carried out using platelets isolated from each of the 15 normal subjects and each of the 8 MSA subjects. Platelets were isolated (7) from venous blood samples (1% EDTA anticoagulant, 1 ml/9 ml blood), taken after 1 h recumbency in normal and MSA subjects at the same time of the day (1400 h), 1 subject's platelets freshly after isolation and then again after overnight storage in incubation buffer (7) at 4°C] were <5%. Intraassay binding variation between duplicate samples of platelets from the same individual (MSA or normal) subject was <4%. All platelet binding assays were carried out immediately after platelet isolation or after storage in incubation buffer overnight (storage before incubation was carried out with platelets from four MSA and four normal subjects (8) .
RESULTS
Norepinephrine pressor responses. The increase in systolic blood pressure was used as a measure of in vivo "alpha receptor" responses and the dose-response curve for normal and MSA subjects is shown in Fig.  1 Fig. 2 for one normal and one MSA subject; the pattern was similar for all normal and MSA subjects. The binding curves of platelets from the individual subjects, in Fig. 2 (Tables I and III) . Nevertheless, nonspecific binding was quantitatively greater in MSA compared with normal platelets (Table III) . For both normal and MSA platelets, the degree of nonspecific binding was saturable. Scatchard analysis of the nonspecific binding curves (Table IV) (Tables III and IV) .
DISCUSSION
All the subjects with MSA and sympathetic degeneration showed denervation supersensitivity of the pressor response to the alpha agonist, norepinephrine, because the dose-response curve for the increase in systolic blood pressure lay to the left of that in normal subjects (Fig. 1) . In terms of the increase in systolic blood pressure, the MSA subjects were -10 times more sensitive to intravenous norepinephrine than normal subjects, confirming the findings of previous studies (4) . This in part represents alpha receptor denervation supersensitivity, but the pressor effect of norepinephrine also results from baroreflex loss and possibly from decreased clearance of norepinephrine, in addition to the supersensitivity resulting directly from denervation of vascular adrenergic receptors (4). The importance of changes in adrenergic receptors in the supersensitivity to norepinephrine was shown by the greater binding of [3H]DHE to platelets isolated from MSA subjects (Fig. 2 , Tables I and II) . Analysis of [3H]DHE binding showed that platelets from MSA subjects had about seven times as many alpha receptors as normal platelets (Table II) . However, Kd values were not significantly different in MSA subjects, thus indicating a similar affinity (9) (15) and the chronotropic response to isoproteronol (16) both decrease with age in man, and in isolated rat heart the inotropic effect of norepinephrine decreases with ageing (17) .
The changes in alpha receptor numbers in the MSA group may be of wider biological significance. Patients with MSA and sympathetic nervous degeneration usually have low concentrations of endogenous norepinephrine in blood (this applies to all MSA subjects in the present study), and the concentration fails to increase with maneuvers such as tilt, which in normal subjects stimulates the sympathetic nervous system with greater spill-over of norepinephrine into the blood (3, 4) . It has been widely suggested that adrenergic receptor number may be regulated in part by the amount of agonist to which a tissue receptor population is exposed: increased amounts of agonist lead to an apparently smaller number of receptors ("desensitization") and decreased amounts of agonist result in a larger number of receptors (18, 19) . Our findings appear to support this view.
In conclusion, this paper shows that denervation supersensitivity in the form of increased in vivo pressor responses to the alpha agonist norepinephrine in subjects with MSA is probably due to the increased alpha receptor numbers.
